Clinical Trials Browser

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Phase 2 Unknown

80 enrolled

Anorexia, Cachexia, Neoplasms

NCT02366884 2022-04-06

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

Phase 2 Unknown

250 enrolled

Tumor-Agnostic

Neoplasms

NCT05147493 2022-03-29

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Phase 2 Unknown

51 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Phase 2 Unknown

108 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT03759496 2022-03-23

Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Phase 2 Unknown

39 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Phase 2 Unknown

300 enrolled

Tumor-Agnostic

Neoplasms

NCT03570437 2022-03-02

COPELIA

Phase 2 Unknown

124 enrolled

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Phase 2 Unknown

27 enrolled

Tumor-Agnostic

Neoplasms

NCT03186404 2022-02-08

SPARE-HF

Phase 2 Unknown

112 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT02595320 2021-12-20

X7-7

Phase 2 Unknown

200 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05097378 2021-10-28

PREMIUM

Phase 2 Unknown

45 enrolled

Dermatologic

Melanoma, Neoplasms

NCT04593563 2021-10-15

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Phase 2 Unknown

30 enrolled

Depressive Disorder, Major, Neoplasms

NCT04547829 2021-09-02

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

Phase 2 Unknown

108 enrolled

Tumor-Agnostic

Neoplasms

NCT03564548 2021-07-28

REBORN

Phase 2 Unknown

20 enrolled

Tumor-Agnostic

Neoplasms

NCT04780854 2021-07-28

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

Phase 2 Unknown

68 enrolled

Tumor-Agnostic

Neoplasms

NCT01676259 2021-07-02

PROTACT

Phase 2 Unknown

80 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT04907864 2021-06-01

MIRACLE

Phase 2 Unknown

112 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02978014 2021-04-19

POPS

Phase 2 Unknown

245 enrolled

Coitus, Neoplasms

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Phase 2 Unknown

1,300 enrolled

Tumor-Agnostic

Neoplasms

NCT04710472 2021-01-14

MentorA1

Phase 2 Unknown

50 enrolled

Tumor-Agnostic

Neoplasms

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Phase 2 Unknown

30 enrolled

Tumor-Agnostic

Neoplasms

NCT04566952 2020-10-30

ANLOLA

Phase 2 Unknown

68 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT01567202 2020-09-09

Study of DC Vaccination Against Glioblastoma

Phase 2 Unknown

100 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT02226289 2020-09-02

BATTLE

Phase 2 Unknown

46 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT04104113 2020-06-16

HERBAL

Phase 2 Unknown

80 enrolled

Fatigue, Neoplasms, Cognitive Dysfunction

NCT04430361 2020-06-12

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Phase 2 Unknown

120 enrolled

Neoplasms, Vomiting

NCT04371796 2020-05-01

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

Phase 2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT04341207 2020-04-10

ONCOVID

Phase 2 Unknown

1,000 enrolled

COVID-19, Neoplasms

Clinical Trials

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

TCM

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

ANZUP2001

MITRAS

SOLUCOM

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Neo Trio

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Clinical Trial of Autologous Tcm Immunotherapy in ICC

Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

ZIDON

COLT

IMPARP-HRD

OPTIMUM

I-HEP

CaEP-R

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

OMNI-Can

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Efficacy and Safety of Precision Therapy in Refractory Tumor

COPELIA

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

SPARE-HF

X7-7

PREMIUM

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

REBORN

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

PROTACT

MIRACLE

POPS

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

MentorA1

Arsenic Trioxide for Structural p53 Mutations

ANLOLA

Study of DC Vaccination Against Glioblastoma

BATTLE

HERBAL

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

ONCOVID